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Aims To evaluate the feasibility and diagnostic performance of high spatial resolution myocardial perfusion cardiac magnetic
resonance (perfusion-CMR).
Methods
and results
Fifty-four patients underwent adenosine stress perfusion-CMR. An in-plane spatial resolution of 1.4   1.4 mm
2 was
achieved by using 5  k-space and time sensitivity encoding (k–t SENSE). Perfusion was visually graded for 16 left
ventricular and two right ventricular (RV) segments on a scale from 0 ¼ normal to 3 ¼ abnormal, yielding a perfusion
score of 0–54. Diagnostic accuracy of the perfusion score to detect coronary artery stenosis of .50% on quanti-
tative coronary angiography was determined. Sources and extent of image artefacts were documented.
Two studies (4%) were non-diagnostic because of k–tSENSE-related and breathing artefacts. Endocardial dark rim
artefacts if present were small (average width 1.6 mm). Analysis by receiver–operating characteristics yielded an area
under the curve for detection of coronary stenosis of 0.85 [95% conﬁdence interval (CI) 0.75–0.95] for all patients
and 0.82 (95% CI 0.65–0.94) and 0.87 (95% CI 0.75–0.99) for patients with single and multi-vessel disease,
respectively. Seventy-four of 102 (72%) RV segments could be analysed.
Conclusion High spatial resolution perfusion-CMR is feasible in a clinical population, yields high accuracy to detect single and
multi-vessel coronary artery disease, minimizes artefacts and may permit the assessment of RV perfusion.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
The use of ﬁrst-pass myocardial perfusion cardiac magnetic
resonance (perfusion-CMR) to detect left ventricular (LV) ischaemia
has been extensively validated.
1–5Combined with an assessment of
ventricular function by cine imaging and viability by late
gadolinium enhancement (late-gadolinium-enhanced-CMR; LGE-
CMR), perfusion-CMR allows for a comprehensive assessment
of coronary artery disease (CAD).
6,7 However, currently
perfusion-CMR yields a substantially lower spatial resolution than
these other CMR methods.
1–11 The main reason for this limitation
is that in a ﬁrst-pass perfusion-CMR study all data have to be
acquired in a single shot in a limited portion of each cardiac cycle.
Acquisition of cine and LGE-CMR data on the other hand can be
segmented and acquired over several heartbeats to boost spatial
resolution and/or signal-to-noise ratio.
New acquisition strategies such as k-space and time sensitivity
encoding (k–t SENSE), that simultaneously exploit coil encoding
and spatiotemporal correlations, allow substantial acceleration
of CMR data acquisition.
12,13 This speed-up can be utilized to
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or increase signal-to-noise ratio. The feasibility of high spatial
resolutionk–tSENSEacceleratedperfusion-CMRhasbeendemon-
strated in principle in volunteers.
14 In clinical application, the high
spatial resolution should have several beneﬁts, including: (i) better
integration of perfusion with cine and LGE-CMR data, (ii) minimal
impact of endocardial dark-banding artefacts, which will be
reducedinextentaccordingtothesmallervoxelsize,and(iii)assess-
ment of the transmural distribution of ischaemia in several myocar-
diallayers.Potentially,thehighspatialresolutionmayalsopermitthe
assessment of perfusion of the thin-walled right ventricular (RV)
myocardium, previously not measurable by perfusion-CMR.
The purpose of this study was to assess the feasibility of high
spatial resolution perfusion-CMR for clinical application and to
determine its diagnostic accuracy to detect ischaemia of the left
and right ventricle and in multi-vessel disease.
Methods
Patients
Patients awaiting diagnostic invasive X-ray coronary angiography for
evaluation of known or suspected CAD were included in the study.
Exclusion criteria were contraindications to CMR (cardiac magnetic
resonance) (incompatible metallic implants, claustrophobia) or adeno-
sine infusion (asthma, AV block), myocardial infarction within 7 days,
unstable angina pectoris and NYHA Class 4 heart failure. Over a pre-
deﬁned period of 6 months, all patients fulﬁlling the inclusion criteria
were prospectively identiﬁed and contacted. Recruitment ended
after 6 months. Out of 136 suitable patients identiﬁed in the recruit-
ment period, 82 declined participation so that 54 patients (42 male,
mean age 59 years, range 39–79) were eventually recruited. All
recruited patients completed the study. Patients were instructed
to refrain from substances containing caffeine for 24 h before the
examination. Cardiac medication was not stopped prior to CMR. All
patients gave written informed consent and the study was approved
by the local ethics review board.
Cardiac magnetic resonance
CMR studies were carried out on a clinical 1.5T MR system (Philips
Medical Systems, Best, The Netherlands) using a ﬁve-element cardiac
phased array receiver coil for signal reception. All CMR data were
acquired in the true short axis of the LV, and in contrast to many previous
CMR studies, data were acquired in end-inspiration. This approach was
chosen to maximize the breath-hold capacity of the patients.
Adenosine was administered intravenously at a dose of 140 mg/kg/min
under continuous heart rate and blood pressure monitoring at 1 min
intervals. After 3 min of the adenosine infusion, an intravenous bolus
injection of 0.1 mmol/kg Gadobutrolum (Gadovist, Schering, Berlin,
Germany) was administered into an antecubital vein on the opposing
arm with the use of a power injector (Medrad Spectris Solaris,
Medrad, Indianola, PA, USA; injection rate 5 mL/s followed by
a 20 mL Saline ﬂush at 5 mL/s). The pulse sequence used for
perfusion-CMR has been described in detail elsewhere.
14 In brief, a
saturation recovery gradient echo pulse sequence accelerated with
k–t SENSE was used with a repetition time of 3.1 ms, echo time of
1.1 ms, ﬂip angle 158, acquisition window 120 ms, spatial resolution
matched to cine and LGE-CMR at 1.4   1.4   10 mm
3. The k–t
SENSE acceleration factor was ﬁve with 11 training proﬁles acquired
interleaved with the undersampled data. In order to sample data
in cardiac phases with minimal bulk cardiac motion and minimize
motion-related artefacts, acquisition was limited to four short-axis
sections acquired at alternate heartbeats. To achieve this, mid-systole
and mid-diastole were identiﬁed on cine images and the trigger delays
for the perfusion acquisition set so that acquisition occurred in these
cardiac phases. The dynamic scan duration for the perfusion study
was adjusted to the breath-hold capability of each individual as deter-
mined by non-contrast enhanced test scans.
In all patients cine and LGE-CMR was also performed in identical
slice orientations and during inspiratory breath-holding using conven-
tional methods (spatial resolution 1.4   1.4   10 mm
3).
Cardiac magnetic resonance analysis
All data were reviewed on a post-processing workstation (Viewforum,
Philips Medical Systems, Best, The Netherlands) by an expert observer
with .5 years experience in reading .100 perfusion-CMR studies per
year. The observer was blinded to all clinical information. For assess-
ment of observer variability, a second expert (3 years experience in
reading .100 perfusion-CMR studies per year) independently repeated
the analysis.
Image quality was graded on a scale between 0 and 3 (0 ¼ non-
diagnostic, 1 ¼ poor, 2 ¼ good, 3 ¼ excellent). Occurrence of
artefacts related to the k–t reconstruction, respiratory motion, and
endocardial dark banding were recorded. It was further noted whether
k–t reconstruction-related and motion artefacts affected the ﬁrst
myocardial contrast passage. Dark-banding artefacts were recorded
if an endocardial dark band appeared at the arrival of contrast in
the LV cavity and prior to contrast arrival in the myocardium. The
maximal transmural width of endocardial dark-banding artefacts was
measured using electronic callipers.
Visual perfusion analysis used 16 segments of the AHA (American
Heart Association) model for LV assessment.
15 The two middle sec-
tions of the perfusion-CMR studies were combined to yield segments
7–12 (mid-ventricular level) of the model. In addition, perfusion of the
RV free wall was assessed for two RV segments (anterior and inferior),
yielding a total of 18 segments per patient. Perfusion in a segment was
considered abnormal if:
† signal enhancement was reduced compared with remote myocardial
segments; or
† an endocardial to epicardial perfusion gradient within a segment was
present; and
† if the perfusion defect was not located within scar tissue on corre-
sponding LGE-CMR images.
Stress perfusion in each segment was scored on a scale from 0 to 3
(0 ¼ normal, 1 ¼ probably normal, 2 ¼ probably abnormal or sub-
endocardial defect, 3 ¼ abnormal or transmural defect). By summing
all segmental scores, a perfusion score of 0–54 was calculated for
each patient. Separate perfusion scores were calculated for the left
anterior descending (LAD), circumﬂex (Cx), and right coronary
artery (RCA) territories according to the AHA segmentation.
15 For
this, the inferior RV segment was added to the RCA perfusion score
and the anterior RV segment to the LAD score.
X-ray coronary angiography
Following the CMR examination, all patients underwent biplane
coronary angiography using a standard technique. Angiograms
were analysed by quantitative coronary analysis (QCA) (Xelera
1.2 L4 SP1, Philips Medical Systems, Best, The Netherlands) by
an independent blinded reviewer. Coronary lesions were analysed
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guiding catheter was used for calibration. The severity of any
coronary lesion was evaluated measuring minimal lumen diameter
and per cent diameter stenosis in several angiographic views.
The most severe stenosis was recorded. For analysis purposes,
only vessels with a reference diameter of .2 mm were included.
Based on these analyses, patients were classiﬁed as having one-,
two-, or three-vessel disease.
Statistical analysis
Statistical analysis used Analyse-it software (Analyse-it, Leeds, UK).
Continuous data were expressed as the mean+SD and compari-
sons between groups were made using two-sided paired t-test for
continuous data. Discrete data were expressed as percentages.
Statistical signiﬁcance was considered for P , 0.05.
Receiver operating characteristic (ROC) analyses were per-
formed to evaluate the diagnostic performance of the perfusion
score to detect coronary stenosis of .50% on QCA.
16 In addition
to this primary analysis, the stenosis severities .70% and .75%,
which have been used in previous studies, were also analysed.
Areas under the curve (AUCs) with 95% conﬁdence intervals
(95% CI) were determined from ROC analysis. Agreement
between observers for the overall perfusion scores was assessed
using the method described by Bland and Altman.
17
Results
All studies were completed. Data from one subject was not
available for analysis because of a reconstruction error. Both
observers scored one additional study as non-diagnostic because
of a combination of ECG gating and respiratory motion artefacts
and one observer excluded another patient on the basis of poor
image quality. Fifty-one patients (94%) were thus available for
the ﬁnal analysis. Clinical details of the study group are given in
Table 1.
Cardiac magnetic resonance imaging
Forty patients experienced side effects during the adenosine infu-
sion (breathlessness, ﬂushing, headache), but no clinically relevant
complications occurred. Heart rate increased from 64+9t o
74+8 b.p.m. (P ¼ 0.0001) during stress, while systolic blood
pressure did not change signiﬁcantly during adenosine infusion
(124+12 to 122+14 mmHg, P ¼ 0.26).
Coronary angiography
X-ray angiography was carried out at a median of 4 days (inter-
quartile range 6) of the CMR study. Of the 51 patients included in
the ﬁnal analysis, 16 (31%) had no coronary artery stenosis of
.50%. Fourteen patients (27%) had one-vessel disease, 17 (33%)
two-vessel disease, three (6%) had three-vessel disease and one
patient (2%) had signiﬁcant left main stem stenosis. Table 1 lists
furtherdetails oftheangiographiccharacteristicsofthestudygroup.
Diagnostic accuracy
Mean perfusion score was 8 (95% CI 6–10), with a median of 6.5
(95% CI 3–10), a range of 29 and an interquartile range of 11.25.
The AUC of the ROC analysis for the ability of the CMR perfusion
score to detect the presence of coronary disease .50% was 0.85
(95% CI 0.75–0.95) (Figure 1). Diagnostic performance was
................................................................................
................................................................................
................................................................................
Table 1 Base-line demographic characteristics, cardiac
risk factors and angiographic ﬁndings of patients
included in the analysis (n 5 51)
Sex, n (%)
Male 39 (76%)
Female 12 (24%)
Age (years)
a 59 (+10)
Risk factors, n (%)
Diabetes mellitus 7 (14%)
Hypertension 35 (68%)
Hypercholesterolaemia 36 (70%)
Previous MI 6 (12%)
Previous PCI 4 (8%)
Smoker 29 (57%)
Angiography ﬁndings
No signiﬁcant disease
b 16 (31%)
One-vessel disease
b 14 (27%)
Two-vessel disease
b 17 (33%)
Three-vessel disease
b 3 (6%)
Left main stem disease
b 1 (2%)
LAD disease
b 20 (39%)
Cx disease
b 17 (33%)
RCA disease
b 22 (43%)
PCI, percutaneous coronary intervention; MI, myocardial infarction; LAD, left
anterior descending artery; Cx, circumﬂex artery; RCA, right coronary artery.
aPlus/minus values are mean+SD.
bCoronary stenosis . 50% on QCA (quantitative coronary analysis).
Figure 1 Receiver–operating characteristics curve for the
ability of the cardiac magnetic resonance perfusion score to
detect coronary artery disease .50%.
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from the analysis. Similar diagnostic performance was seen at
coronary stenosis levels of .70 and .75% (AUC 0.83, 95% CI
0.71–0.95 and 0.84, 95% CI 0.73–0.95, respectively). Diagnostic
accuracy was similar for single and multi-vessel (two- or three-
vessel) disease (at disease severity .50%: AUC 0.82, 95% CI
0.70–0.94 vs. 0.87, 95% CI 0.75–0.99, respectively). Table 2 lists
all results of one-vessel and multi-vessel disease at different
disease severities.
AUC of the ROC analysis were 0.78 (95% CI 0.64–0.94), 0.82
(95% CI 0.68–0.96), and 0.80 (95% CI 0.66–0.94) for the
detection of .50% coronary stenosis in the LAD, Cx, and RCA,
respectively.
Correlation with other cardiac magnetic
resonance components
In one half (three of six) of the patients with previous myocardial
infarction, peri-infarct ischaemia was demonstrated by perfusion-
CMR. An example is shown in Figure 2 from a patient with previous
inferior myocardial infarction, chronic total occlusion of the RCA,
and ongoing angina following elective percutaneous intervention to
the proximal LAD. LGE-CMR images demonstrated an inferior scar
at mid-ventricular and basal levels with corresponding wall motion
abnormalities on cine imaging. Perfusion-CMR identiﬁed inferior
peri-infarct ischaemia in viable myocardium around the scar. No
ischaemia was seen in the LAD territory. The patient’s symptoms
...............................................................................................................................................................................
Table 2 Areas under the receiver–operating characteristics curves and 95% conﬁdence interval (CI) for the detection of
coronary stenosis at different disease severities and disease extent. Given in brackets are the numbers of patients with
one or multi-vessel disease at the three disease severity cut-offs
>50% >70% >75%
One-vessel disease 0.82 (0.70–0.94) (n ¼ 14) 0.81 (0.70–0.92) (n ¼ 14) 0.87 (0.75–0.99) (n ¼ 14)
Multi-vessel disease 0.87 (0.75–0.99) (n ¼ 21) 0.86 (0.73–0.99) (n ¼ 18) 0.81 (0.68–0.94) (n ¼ 14)
Figure 2 Case example: 47-year-old male with previous inferior myocardial infarction, in whom subsequent coronary angiography showed
chronic total occlusion of the right coronary artery and a patent proximal left anterior descending artery stent. The top row shows adenosine
stress myocardial perfusion images at peak myocardial contrast enhancement, the middle row the corresponding late-gadolinium enhanced
images and the bottom row matching frames from the cine data sets. An infero-basal scar with thinning of the myocardium can be seen in
all images. Perfusion images show peri-infarct ischaemia extending circumferentially outside the scar at the basal level (arrows). In addition,
there is ischaemia in the viable apical inferior segments. The correlation of the cardiac magnetic resonance components is facilitated by
their identical orientation and spatial resolution.
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RCA territory. Subsequent invasive angiography conﬁrmed the
chronic occlusion of the RCA and a patent LAD stent. An attempt
to open the RCA occlusion failed.
Right ventricular perfusion
Seventy-four of 102 (72%) of RV segments could be analysed.
In the remaining segments the RV free wall could not be clearly
differentiated from blood pool or extra-cardiac tissue during the
ﬁrst pass of the contrast agent. In ﬁve patients RV ischaemia was
detected and was speciﬁc for proximal RCA disease (ﬁve out of
ﬁve). Figure 3A shows normal RV perfusion in a patient with
normal RCA and LAD, Figure 3B normal RV perfusion in a
patient with a mid-RCA lesion, and Figure 3C inferior RV ischaemia
in a patient with a proximal RCA stenosis.
Image quality and artefacts
Figure 4 illustrates the dynamic transmural redistribution of blood
ﬂow during the ﬁrst pass of the contrast passage in a patient
with a stenosis in the proximal LAD (90% on QCA). In Figure 4A
and B images acquired in the early part of the myocardial contrast
passage reveal a transmural perfusion defect which becomes
subendocardial in the later stages of the contrast passage in
Figure 4C and D.
The mean image quality score was 1.9. Dark-banding artefacts
were seen in 25 data sets, but were limited to the endocardial
border of diastolic images and measured on average 1.6 mm in
width. There were no cases in which dark-banding artefacts
were reported as signiﬁcant. A typical dark-banding artefact can
be seen in the most basal slice of Figure 4A. Five data sets were
affected by k–t reconstruction artefacts, all in patients who were
unable to hold their breath for the duration of the scan
(Figure 5). Two of these studies were excluded from the analysis
because artefacts affected the myocardial contrast passage, while
in the other three the myocardial contrast passage was unaffected
by the artefacts.
Interobserver agreement
Out of 816 segments analysed, the observers awarded the same
segmental perfusion score in 650 (79.8%). The same score or
one grade difference was given for 756 segments (92.8%). Agree-
ment analysis for the overall perfusion score showed a mean
bias of 20.8 with 95% limits of agreement of 211.8 (95% CI
214.5 to 29.0) to 10.2 (95% CI 7.5–12.9). Image quality scores
were similar between both observers (1.9 vs. 1.8, P ¼ 0.12) with
a one-grade difference in six patients. AUC of the ROC analysis
were similar for the main analysis of coronary stenosis .50%:
0.85 (95% CI 0.75–0.95) vs. 0.83 (95% CI 0.72–0.94), P ¼ 0.75.
Discussion
This study shows that stress perfusion-CMR at high spatial
resolution, facilitated by k–t SENSE acceleration, can be applied to
a clinical population with suspected CAD. Visual analysis of the
data provides high diagnostic accuracy for the detection of coronary
stenosis in single and multi-vessel disease. The high spatial resolution
facilitates an integrated analysis of perfusion, cine, and LGE-CMR
data and may permit the assessment of RV perfusion.
The potential of CMR to provide a comprehensive assessment
of CAD has long been recognized. Cine and LGE-CMR are today
considered gold standards for the assessment of contractile function
and scar because of their high spatial resolution, tissue contrast,
and diagnostic accuracy.
8–11 Despite similar image properties and
theoretical advantages over competing imaging modalities, myocar-
dial perfusion-CMR has been less enthusiastically embraced in
clinical practice. The reasons for this include a lack of consistent
acquisition protocols between vendors and institutions, lack of
simple analysis tools and less consistent image quality. In addition,
lower spatial resolution compared with cine and LGE-CMR and
related limitations such as dark-banding artefacts have affected the
use of perfusion-CMR in the past.
1–5
This study demonstrates that adenosine stress perfusion-CMR at
a spatial resolution similar to other CMR methods is achievable
with 5  k–t SENSE acceleration. The high spatial resolution had
several beneﬁcial effects:
Figure 3 Case examples of right ventricular (RV) perfusion. Images from perfusion-cardiac magnetic resonance of three patients. Only one
slice of the four acquired sections and only the dynamic image with the clearest contrast between RV free wall and blood pool are shown. (A)
Normal RV perfusion in a patient with a normal right coronary artery (RCA) and left anterior descend artery (white arrows). (B) Normal RV
perfusion is seen in a patient with a mid-RCA lesion and ischaemia in the inferior segment of the left ventricle (LV) (black arrow) due to a
mid-vessel occlusion of the RCA. (C) Inferior RV (white arrows) and LV (black arrow) ischaemia can be seen in a patient with a proximal
RCA stenosis. The white arrows point to high signal in the anterior RV wall and low signal in the inferior RV wall, suggesting reduced perfusion
in the RV inferior segment, which is most evident when compared with normal inferior RV perfusion in the examples shown in (A) and (B).
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the image examples illustrate and only 2 of 54 studies were
considered non-diagnostic. Subendocardial dark rim artefacts
were small,
18,19 as demonstrated in Figure 4, and their diagnostic
impact was minimal. Observer agreement was high for overall as
well as segmental analysis.
Figure 4 Case example: myocardial perfusion-cardiac magnetic resonance study of a 56-year-old patient with 90% stenosis of the left anterior
descending coronary artery on subsequent coronary angiography. Four slices were acquired from the base (left) to the apex (right) and images
at four time points during the contrast passage are shown from (A)t o( D). In (A) and (B) images acquired in the early part of myocardial enhance-
ment reveal a transmural perfusion defect, which becomes subendocardial in the washout phase of the contrast passage in (C) and (D). The left
column shows a typical dark-banding artefact at the inferior septum. This artefact is most pronounced early during the contrast passage, reduces
rapidly during contrast uptake in the myocardium, and in line with the high spatial resolution has a small transmural extent.
Figure 5 Respiratory and k–treconstruction-related artefact: perfusion-cardiac magnetic resonance images from a patient who was unable to
hold his breath during the stress-perfusion acquisition. Images from left to right show dynamic images reconstructed for different time points of
the acquisition. The ﬁrst and last images show reconstruction errors due to respiratory motion, whilst images during the myocardial contrast
passage are relatively free of artefact, allowing an assessment of myocardial perfusion as normal.
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andLGE-CMRdata.Althoughthecorrelationofdifferentcomponents
ofaCMRstudydoesnotdependontheirresolutionalone,butalsoon
acquiring data in the same spatial orientation, similar spatial resolution
between the components facilitates, in particular, the analysis of
patients with complex cardiovascular disease and previous
myocardial infarction as shown in Figure 3. LGE-CMR is increasingly
used for viability assessment in patients with known CAD, and the
diagnosticvalueofCMRwillbeenhancedifotherCMRcomponents
match in both spatial orientation as well as resolution.
Thirdly, the transmural extent of perfusion and its evolution
over time were clearly delineated, as Figure 4 shows. The trans-
mural ischaemia gradient seen between multiple cardiac layers
provided an additional marker of ischaemia, which was helpful in
particular in detecting multi-vessel disease. Conventionally the
visual analysis of perfusion-CMR data requires comparison with a
normally perfused reference segment. This dependence on an
intra-patient comparison is often regarded as an important
impediment of visual analysis compared with semi-quantitative
3,5
and quantitative
20 analysis methods, in particular for the detection
of balanced ischaemia in multi-vessel disease. Adding the trans-
mural ischaemia distribution as a diagnostic marker of ischaemia
in this study resulted in a similar diagnostic accuracy for detection
of multi-vessel disease as for single vessel disease and may
represent an important improvement of visual analysis of
perfusion-CMR studies. However, this study has not shown a
better diagnostic performance of high resolution perfusion-CMR
compared with the published literature with previous methods
and lower spatial resolution. A comparative study is needed
to determine whether higher spatial resolution perfusion-CMR
translates into improved diagnostic yield.
Recently, perfusion-CMR at 3 Tesla has been described with
promising initial results.
21 k–t SENSE can be applied irrespective
of the ﬁeld strength and the SNR increase at 3 Tesla will partly
compensate for the loss of SNR associated with higher spatial res-
olution and spatiotemporal undersampling. k–tSENSE accelerated
perfusion-CMR at 3 Tesla is thus an attractive prospect.
This study also showed for the ﬁrst time that perfusion-CMR has
the potential to delineate RV ischaemia. Because the normal RV
free wall is very thin, the visualization of its blood supply is challen-
ging. Other diagnostic tests, in particular nuclear scintigraphy
and echocardiography, are faced with similar challenges.
22,23 As
shown, the high spatial resolution achieved in this work potentially
allows the detection of RV ischaemia with perfusion-CMR,
although our data are clearly preliminary and the number of
patients with RV ischaemia (n ¼ 5) was too small to draw ﬁrm
conclusions. The main reason why RV perfusion could not be
evaluated in one-third of patients was contrast agent persistence
or recirculation into the RV cavity at the time of myocardial
perfusion. Modiﬁcations of the contrast dose or injection speed
might be necessary to optimize assessment of RV perfusion.
Data in this study were analysed at three stenosis levels of 50, 70,
and 75% to permit a comparison with previous studies in which
different cut-off levels were used to deﬁne signiﬁcant stenosis.
Reassuringly, the overall diagnostic performance of perfusion-CMR
was similar at all stenosis severities, although CIs were wide given
the small sample size.
As in the previous volunteer study,
14 data acquisition in this
work was limited to systole and diastole with four slices acquired
over two heartbeats. The motivation for limiting data acquisition to
mid-systole and mid-diastole was to minimize artefacts related to
cardiac motion and thus permit a more conﬁdent identiﬁcation
of potential artefacts related to the new method itself. It needs
to be emphasized that the decision was entirely independent of
the evaluation of the k–t SENSE method. Although it would
have been possible to acquire additional slices, given the shot dur-
ation of 120 ms, the diagnostic accuracy of perfusion-CMR studies
is not enhanced by acquiring additional slices in particular if they fall
into phases of the cardiac cycle with rapid motion.
4,24 In order to
compensate for the lower temporal resolution of acquisition at
alternate heartbeats, we used a relatively high contrast medium
dose of 0.1 mmol/kg compared with previous studies so that the
wash-in phase was considerably prolonged. As illustrated in
Figure 4, with this approach ischaemia persisted for several
dynamic images.
Limitations
Like the majority of previous perfusion-CMR studies, we used
X-ray coronary angiography to determine the presence of signiﬁ-
cant coronary stenosis. Due to local clinical management, invasive
functional assessment of coronary stenoses was not available for all
patients. Although the limitations of the X-ray angiogram to deter-
mine the functional signiﬁcance of borderline coronary stenosis are
well documented, it remains the most important clinical test to
determine the need for revascularization in the real world.
k–tSENSE adds complexity to the acquisition of perfusion-CMR
data. In particular, the method is sensitive to respiratory motion
and cardiac arrhythmia. In this study, respiratory motion during
data acquisition was found to affect not only the image frame(s)
experiencing motion but also frames neighbouring in time
(Figure 5). This observation relates to the periodicity assumed in
the k–t SENSE reconstruction. However, breathing typically
occurred towards the end of the acquisition and thus affected
the last and ﬁrst image frames, while data acquired during the myo-
cardial contrast passage were generally artefact-free. Importantly,
in our unselected clinical population only two patients (4%) had
to be excluded from analysis because artefacts affected the myo-
cardial contrast passage.
Conclusions
High spatial resolution perfusion-CMR is feasible in a clinical popu-
lation. It accurately detects coronary artery stenosis in single
and multi-vessel CAD, minimizes artefacts, and shows potential
for an assessment of RV ischaemia. High spatial resolution
perfusion-CMR may also provide an improved tool for the evalu-
ation of conditions or therapies that predominantly affect subendo-
cardial perfusion.
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